바로가기메뉴

본문 바로가기 주메뉴 바로가기
 

logo

  • KOREAN
  • P-ISSN3022-6805
  • E-ISSN3022-6791
  • KCI

A Case of Improvement of Excess Body Fat Using Ortho-Cellular Nutrition Therapy (OCNT)

CELLMED / CELLMED, (P)3022-6805; (E)3022-6791
2025, v.15 no.11, pp.3-3
https://doi.org/10.5667/CellMed.spc.137
Ayoung Lee (365 Olive Pharmacy)

Abstract

Objective: Body fat is a connective tissue present in the human body that plays an essential role such as energy storage, protection of organs from external shocks, and the regulation of hormonal responses. However, when present in excess, it increases the incidence and mortality of chronic diseases, making proper management necessary. To this end, various methods have been employed, including lifestyle modification, pharmacological treatment, and surgical approaches. Recently, therapeutics targeting GLP-1 receptors have attracted attention. Nevertheless, adverse effects such as gastrointestinal disorders and gallbladder complications have been reported, leading to growing interest in natural product–based GLP-1 receptor agonists with fewer side effects as alternatives. Case Report: The subject of this case study was a Korean woman in her twenties who was diagnosed with excess body fat through a body composition test and wished to manage it. Accordingly, ortho-cellular nutrition therapy (OCNT), using ingredients such as turmeric, hibiscus, bitter melon, barberry, green tea, and Garcinia cambogia, was prescribed. After one week of OCNT, a follow-up body composition test confirmed that the patient’s body fat mass and body fat percentage had changed to within the reference range. Conclusion: Appropriate OCNT tailored to an individual’s physical condition and circumstances may help reduce body fat. However, since this case study was conducted with a single subject, further research is required to investigate OCNT prescriptions suited to other populations.

keywords
Ortho-Cellular Nutrition Therapy (OCNT), body fat, body composition, GLP-1
Received
2025-08-27
Revised
2025-08-28
Accepted
2025-08-29
Published
2025-08-29

CELLMED